Abstract:Objective To evaluate the clinical results of treatment for osteosarcoma of the extremities with adjuvant chemotherapy regimen Methods Sixty seven patients with ⅡB extremity osteosarcoma were treated with the combination of adjuvant chemotherapy regimen and definitive surgery Forty seven of them were male and twenty four were female The mean age of the patients at the time of diagnosis was 20 years (ranged 10～51 years) Sixty four lesions involved the lower extremity, with 45 involving the distal femur, 14 the upper tibia, 3 the upper fibula and 2 the proximal femur; Three involved the upper end of the humerus The study of subtype of osteosarcoma revealed that 51 were osteoblastic, 6 chondroblastic, 5 fibroblastic and 5 the other subtypes The patients were divided into three groups according to the adjuvant chemotherapy regimen given, the first group consisted of 23 cases, who were treated with the combination of the presurgical cisplatin hyperthermic isolated limb perfusion (CDP-HILP) and postoperative chemotherapy; the second group of 20 cases, who were treated with the combination of the presurgical CBP-HILP and postoperative chemotherapy; and the other 24 cases were treated with postoperative chemotherapy alone Twenty nine of the 67 patients treated surgically had limb salvage procedures; 35 had amputations and 3 had Tikhoff-Limbergs surgery Multiple histologic sections were procured and examined from each of the surgical specimens in the patients who were treated with preoperative HILP to determine the effect of chemotherapy All patients were followed from 3 to 9 years, and the data were statistically analeyed using SPSS 7 0 Results Among 67 cases, 41 (61 19%) had relapse free survival(RFS) in 2 years after surgery, 37 (55 22%) had RFS in 3 years after surgery, and RFS probability at 5 years after surgery was 49 56% Log-rank analysis showed no significant difference in RFS probability among the three groups(P=0 517 1), but there was a significant difference in RFS probability between patients who had limb salvage procedure and those had amputation(P=0 009 7) Age, sex, site and subtype were not significant prognostic variables in this group of patients Correction analysis revealed that the RFS probability were not related with the rate of the tumor necrosis (P=0 058) Conclusion The data revealed that 1) The chemotherapy regimen mainly including platinic drugs was effective treatment for osteosarcoma ,and was more simple and less expensive than any previous reported chemotherapy for steosarcoma, 2) CDP of chemotherapy regimen for osteosarcoma, which had more nephritic and audio toxicity could be replaced by CBP , And 3)Whether the preoperative chemotherapy is suitable for the patients in whom amputation is inevitable (based on age ,size, and involvement of local structure) remains unclear

[Prognostic Factors for 72 Patients with Osteosarcoma of the Extremity Treated with Neoadjuvant Chemotherapy].

Multivariate Analysis of Chondrosarcoma Prognosis

Multivariate analysis of the prognosis of 37 chondrosarcoma patients.

The diuleal features and prognostic factors of osteosarcoma in adult

The Treatment of Stage III Osteosarcoma

The Survival of Patients with Osteosarcoma Influenced by Chemotherapy Induced Tumor Necrosis and Tumor Volume Variation, the Chinese Experience

The assessment of the effectiveness of the adjuvant chemotherapy regimen for the treatment of osteosarcoma

Predicting Survival of Patients with Bone Metastasis of Unknown Origin

[Evaluation of Neoadjuvant Chemotherapy for Patients with Stage II Osteosarcoma].

Clinical Factors Affecting Prognosis of Limb Osteosarcoma in China: a Multicenter Retrospective Analysis.

Three Hematological Indexes That May Serve As Prognostic Indicators in Patients with Primary, High-Grade, Appendicular Osteosarcoma

A Multi-Center Retrospective Analysis of Clinical Prognosis in Children with Extremity Osteosarcoma

Surgical Treatment and Prognostic Analysis of Osteosarcoma in Adults Older Than 40 Years

Prognostic Factors in Osteosarcoma: A Study Level Meta-Analysis and Systematic Review of Current Practice

A multi-center retrospective study on the clinical prognosis of limb osteosarcoma

Prognostic Factors for Survival among Patients with Primary Bone Sarcomas of Small Bones

Prognostic Factors and Outcome for 99 Osteosarcoma Patients with Pulmonary Metastases

Prognostic factors and treatment outcomes of spinal osteosarcoma: Surveillance, epidemiology, and end results database analysis

Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.

Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET

Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma